| 1 | [SID87544714] | Active | IC50 | 6.51 | SAR analysis of compounds that inhibit Human Immunodeficiency Virus Fusion. [AID434967, Type: confirmatory] | envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 87544714 | | CID | 24819152 | | Outcome | Active | | IC50 | 6.51 [uM] | | BioAssay | SAR analysis of compounds that inhibit Human Immunodeficiency Virus Fusion. | | AID | 434967 | | BioAssay type | confirmatory | | Target | envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394] | | PubMed | | | Data Table |  |
|
| 2 | [SID87544714] | Active | IC50 | 8 | SAR analysis of compounds that inhibit Human Immunodeficiency Virus Fusion, cell-cell fusion assay [AID435029, Type: confirmatory] | envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 87544714 | | CID | 24819152 | | Outcome | Active | | IC50 | 8 [uM] | | BioAssay | SAR analysis of compounds that inhibit Human Immunodeficiency Virus Fusion, cell-cell fusion assay | | AID | 435029 | | BioAssay type | confirmatory | | Target | envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394] | | PubMed | | | Data Table |  |
|
| 3 | [SID49826111] | Active | Potency | 10.2412 | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation [AID588347, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | Potency | 10.2412 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation | | AID | 588347 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 4 | [SID49826111] | Active | Potency | 10.2412 | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation [AID588347, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | Potency | 10.2412 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation | | AID | 588347 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 5 | [SID49826111] | Active | IC50 | 13.8038 | Dose responses of compounds that inhibit the Choline Transporter (CHT) - 5 point CRC [AID504840, Type: confirmatory] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | IC50 | 13.8038 [uM] | | BioAssay | Dose responses of compounds that inhibit the Choline Transporter (CHT) - 5 point CRC | | AID | 504840 | | BioAssay type | confirmatory | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 6 | [SID49826111] | Active | IC50 | 13.8038 | Dose responses of compounds that inhibit the Choline Transporter (CHT) - 5 point CRC [AID504840, Type: confirmatory] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | IC50 | 13.8038 [uM] | | BioAssay | Dose responses of compounds that inhibit the Choline Transporter (CHT) - 5 point CRC | | AID | 504840 | | BioAssay type | confirmatory | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 7 | [SID49826111] | Active | IC50 | 16.9 | uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors. [AID1986, Type: confirmatory] | envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | IC50 | 16.9 [uM] | | BioAssay | uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors. | | AID | 1986 | | BioAssay type | confirmatory | | Target | envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394] | | PubMed | | | Data Table |  |
|
| 8 | [SID49826111] | Active | Potency | 28.1838 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 9 | [SID49826111] | Active | Potency | 28.1838 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 10 | [SID49826111] | Active | Potency | 29.8247 | Confirmation Assay for Inhibitors of Human Galactokinase (GALK) [AID2015, Type: confirmatory] | galactokinase [Homo sapiens] [gi:4503895] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | Potency | 29.8247 [uM] | | BioAssay | Confirmation Assay for Inhibitors of Human Galactokinase (GALK) | | AID | 2015 | | BioAssay type | confirmatory | | Target | galactokinase [Homo sapiens] [gi:4503895] | | PubMed | | | Data Table |  |
|
| 11 | [SID49826111] | Active | Potency | 29.8247 | Confirmation Assay for Inhibitors of Human Galactokinase (GALK) [AID2015, Type: confirmatory] | galactokinase [Homo sapiens] [gi:4503895] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | Potency | 29.8247 [uM] | | BioAssay | Confirmation Assay for Inhibitors of Human Galactokinase (GALK) | | AID | 2015 | | BioAssay type | confirmatory | | Target | galactokinase [Homo sapiens] [gi:4503895] | | PubMed | | | Data Table |  |
|
| 12 | [SID49826111] | Active | EC50 | 50 | A Cell Based Assay for the Identification of Lead Compounds with Inhibitory Activity against HIV-1 Fusion (CCR5 Tropic HIV-1 Fusion Inhibition Assay) - Cytotoxicity Counter Screen - Dose Response [AID2286, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | EC50 | 50 [uM] | | BioAssay | A Cell Based Assay for the Identification of Lead Compounds with Inhibitory Activity against HIV-1 Fusion (CCR5 Tropic HIV-1 Fusion Inhibition Assay) - Cytotoxicity Counter Screen - Dose Response | | AID | 2286 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID87544714] | Active | IC50 | 78.5 | A Cell Based Assay for the Characterization of Lead Compounds with Antiviral Activity against HIV-1 (CCR5-Tropic HIV-1 MAGI Antiviral Assay) - Secondary Assay (2) [AID2788, Type: confirmatory] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 87544714 | | CID | 24819152 | | Outcome | Active | | IC50 | 78.5 [uM] | | BioAssay | A Cell Based Assay for the Characterization of Lead Compounds with Antiviral Activity against HIV-1 (CCR5-Tropic HIV-1 MAGI Antiviral Assay) - Secondary Assay (2) | | AID | 2788 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID87544714] | Active | CC50 | 91 | SAR analysis of compounds that inhibit Human Immunodeficiency Virus Fusion, cytoxicity assay [AID435031, Type: confirmatory] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 87544714 | | CID | 24819152 | | Outcome | Active | | CC50 | 91 [uM] | | BioAssay | SAR analysis of compounds that inhibit Human Immunodeficiency Virus Fusion, cytoxicity assay | | AID | 435031 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID49826111] | Active | | | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS [AID485317, Type: screening] | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | BioAssay | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS | | AID | 485317 | | BioAssay type | screening | | Target | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] | | PubMed | | | Data Table |  |
|
| 16 | [SID49826111] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) [AID492953, Type: screening] | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) | | AID | 492953 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] | | PubMed | | | Data Table |  |
|
| 17 | [SID49826111] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) [AID493034, Type: screening] | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) | | AID | 493034 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] | | PubMed | | | Data Table |  |
|
| 18 | [SID49826111] | Active | | | uHTS fluorescent assay for identification of inhibitors of ATG4B [AID504462, Type: screening] | cysteine protease ATG4B isoform a [Homo sapiens] [gi:47132611] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | BioAssay | uHTS fluorescent assay for identification of inhibitors of ATG4B | | AID | 504462 | | BioAssay type | screening | | Target | cysteine protease ATG4B isoform a [Homo sapiens] [gi:47132611] | | PubMed | | | Data Table |  |
|
| 19 | [SID49826111] | Active | | | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling [AID588675, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling | | AID | 588675 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 20 | [SID49826111] | Active | | | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling [AID588675, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling | | AID | 588675 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 21 | [SID49826111] | Active | Potency | | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) [AID652105, Type: confirmatory] | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) | | AID | 652105 | | BioAssay type | confirmatory | | Target | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] | | PubMed | | | Data Table |  |
|
| 22 | [SID49826111] | Active | | | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay [AID588402, Type: other] | phospholipase A2 precursor [Homo sapiens] [gi:4505847] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | BioAssay | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay | | AID | 588402 | | BioAssay type | other | | Target | phospholipase A2 precursor [Homo sapiens] [gi:4505847] | | PubMed | | | Data Table |  |
|
| 23 | [SID49826111] | Active | | | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay [AID588402, Type: other] | phospholipase A2 precursor [Homo sapiens] [gi:4505847] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | BioAssay | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay | | AID | 588402 | | BioAssay type | other | | Target | phospholipase A2 precursor [Homo sapiens] [gi:4505847] | | PubMed | | | Data Table |  |
|
| 24 | [SID49826111] | Active | | | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) [AID488975, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) | | AID | 488975 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 25 | [SID49826111] | Active | | | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) [AID488975, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) | | AID | 488975 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 26 | [SID49826111] | Active | | | Confirmatory screen for compounds that inhibit the Choline Transporter (CHT) [AID493221, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that inhibit the Choline Transporter (CHT) | | AID | 493221 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 27 | [SID49826111] | Active | | | Confirmatory screen for compounds that inhibit the Choline Transporter (CHT) [AID493221, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that inhibit the Choline Transporter (CHT) | | AID | 493221 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 28 | [SID49826111] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 29 | [SID49826111] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 30 | [SID87544714] | Inactive | TC50 | 100 | A Cell Based Assay for the Characterization of Lead Compounds with Antiviral Activity against HIV-1 (CCR5-Tropic HIV-1 MAGI Antiviral Assay) - Secondary Cytotoxicity Screen (2) [AID2812, Type: confirmatory] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 87544714 | | CID | 24819152 | | Outcome | Inactive | | TC50 | 100 [uM] | | BioAssay | A Cell Based Assay for the Characterization of Lead Compounds with Antiviral Activity against HIV-1 (CCR5-Tropic HIV-1 MAGI Antiviral Assay) - Secondary Cytotoxicity Screen (2) | | AID | 2812 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID49826111] | Inactive | | | qHTS of Yeast-based Assay for SARS-CoV PLP [AID485353, Type: confirmatory] | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | BioAssay | qHTS of Yeast-based Assay for SARS-CoV PLP | | AID | 485353 | | BioAssay type | confirmatory | | Target | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] | | PubMed | | | Data Table |  |
|
| 32 | [SID49826111] | Inactive | | | qHTS of Yeast-based Assay for SARS-CoV PLP [AID485353, Type: confirmatory] | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | BioAssay | qHTS of Yeast-based Assay for SARS-CoV PLP | | AID | 485353 | | BioAssay type | confirmatory | | Target | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] | | PubMed | | | Data Table |  |
|
| 33 | [SID49826111] | Inactive | | | qHTS of Yeast-based Assay for SARS-CoV PLP [AID485353, Type: confirmatory] | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | BioAssay | qHTS of Yeast-based Assay for SARS-CoV PLP | | AID | 485353 | | BioAssay type | confirmatory | | Target | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] | | PubMed | | | Data Table |  |
|
| 34 | [SID49826111] | Inactive | | | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate [AID651958, Type: screening] | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate | | AID | 651958 | | BioAssay type | screening | | Target | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] | | PubMed | | | Data Table |  |
|
| 35 | [SID49826111] | Inactive | | | uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID493012, Type: screening] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | BioAssay | uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 493012 | | BioAssay type | screening | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 36 | [SID49826111] | Inactive | Potency | | qHTS for Inhibitors of Vif-A3G Interactions: qHTS [AID602310, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Vif-A3G Interactions: qHTS | | AID | 602310 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 37 | [SID49826111] | Inactive | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 38 | [SID49826111] | Inactive | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 39 | [SID49826111] | Inactive | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 40 | [SID49826111] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 41 | [SID49826111] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 42 | [SID49826111] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 43 | [SID49826111] | Inactive | | | uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase [AID2805, Type: screening] | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase | | AID | 2805 | | BioAssay type | screening | | Target | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] | | PubMed | | | Data Table |  |
|
| 44 | [SID49826111] | Inactive | | | uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase [AID2806, Type: screening] | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase | | AID | 2806 | | BioAssay type | screening | | Target | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] | | PubMed | | | Data Table |  |
|
| 45 | [SID49826111] | Inactive | Potency | | qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504466, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504466 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 46 | [SID49826111] | Inactive | | | Counter screen assay of the parental HEK293 cells for compounds that inhibit the Choline Transporter (CHT) [AID493222, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | BioAssay | Counter screen assay of the parental HEK293 cells for compounds that inhibit the Choline Transporter (CHT) | | AID | 493222 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 47 | [SID49826111] | Inactive | | | Counter screen assay of the parental HEK293 cells for compounds that inhibit the Choline Transporter (CHT) [AID493222, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | BioAssay | Counter screen assay of the parental HEK293 cells for compounds that inhibit the Choline Transporter (CHT) | | AID | 493222 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 48 | [SID49826111] | Inactive | | | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) [AID488977, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) | | AID | 488977 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 49 | [SID49826111] | Inactive | | | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) [AID488977, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) | | AID | 488977 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 50 | [SID49826111] | Inactive | IC50 | | uHTS identification of small molecule antagonists of the binding of Siah-1 and a peptide ligand via a fluorescence polarization assay. [AID1817, Type: confirmatory] | plectin 1 [Homo sapiens] [gi:40849930] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49826111 | | CID | 24819152 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS identification of small molecule antagonists of the binding of Siah-1 and a peptide ligand via a fluorescence polarization assay. | | AID | 1817 | | BioAssay type | confirmatory | | Target | plectin 1 [Homo sapiens] [gi:40849930] | | PubMed | | | Data Table |  |
|